Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of ALT-801 in Patients With Progressive Metastatic Malignancies

NCT00496860 is registered in ClinicalTrials.gov with Altor BioScience as lead sponsor.

NCT NCT00496860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00496860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of ALT-801 in Patients With Progressive Metastatic Malignancies
Lead sponsor
Altor BioScience
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2007
Completion date
October 31, 2009
Enrollment
26 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

progressive metastatic malignancies